Clinical resistance to topoisomerase-targeted drugs
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1400 (1-3) , 275-288
- https://doi.org/10.1016/s0167-4781(98)00141-9
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Cancer UndefeatedNew England Journal of Medicine, 1997
- DNA topoisomerase II mutations and resistance to anti‐tumor drugsBioEssays, 1995
- Genistein resistance in human leukaemic CCRF-CEM cells: Selection of a diploid cell line with reduced DNA topoisomerase II β isoformBiochemical Pharmacology, 1995
- Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.Proceedings of the National Academy of Sciences, 1993
- Drug resistance associated with altered DNA topoisomerase IIAdvances in Enzyme Regulation, 1993
- Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1992
- Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicinNucleic Acids Research, 1990
- Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase InhibitorsJNCI Journal of the National Cancer Institute, 1989
- Characterization of an Amsacrine-resistant Line of Human Leukemia CellsJournal of Biological Chemistry, 1989
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966